Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor that senses mechanical ...
Researchers may have found a key mechanism underlying idiopathic pulmonary fibrosis, a usually fatal lung disease for which transplantation is the only successful treatment. The investigators found ...
The Fontan operation and its variants have become the procedures of choice in patients with one anatomical or functional ventricular chamber. In a normal biventricular heart, the systemic and ...
Ferrer is using Pulmonary Hypertension Awareness Month to sound the alarm about the shortcomings of the current pathways for diagnosing and treating the blood pressure condition. The Spanish company ...
Please provide your email address to receive an email when new articles are posted on . In PAH lung samples, researchers observed elevated asporin levels and found a link between these levels and ...
Most patients with familial primary pulmonary hypertension have defects in the gene for bone morphogenetic protein receptor II (BMPR2), a member of the transforming growth factor β (TGF-β) superfamily ...
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Chart of human respiratory and ...
The FDA approved sotatercept (Winrevair) for treating pulmonary arterial hypertension (PAH) in adults, Merck announced on Tuesday. A novel activin signaling inhibitor, sotatercept is indicated to ...
MANHASSET, N.Y.--(BUSINESS WIRE)--Ultrasound could one day complement or even replace drugs to treat diseases. Bioelectronic medicine scientists at The Feinstein Institutes for Medical Research used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results